Beta The Briev beta is out. Free on iPhone via TestFlight — install it in under a minute.

Join the beta ↗
Briev
Live
Politics

India's drug regulator tasked with tightening controls on narcotic medicines by 2027

The CDSCO has been ordered to close regulatory gaps and curb illegal diversion of pharma drugs containing narcotic substances by March 2027.

At the recent apex-level NCORD gathering, Union home minister Amit Shah highlighted the growing sophistication of drug traffickers, including the use of encrypted messaging, darknet markets, cryptocurrencies, synthetic compounds and drones. In response, the Central Drugs Standard Control Organization (CDSCO) was assigned a central role in a 2026-2029 drug-control vision document, which sets out a coordinated framework to tackle evolving trafficking and abuse.

The agency must eliminate regulatory gaps that allow illegal diversion of pharmaceutical products containing narcotic substances, with a concrete deadline of March 2027. One of its immediate objectives is to achieve this by March of the following year. Shah also stressed the need for a comprehensive approach covering supply reduction, demand reduction, treatment, rehabilitation and capacity building, especially among youth. The move signals a shift from seizure-centric policing to a more intelligence-focused, technology-enabled enforcement model.

Why it matters

Tighter regulation aims to prevent misuse of prescription narcotics and curb organized drug crime in India.

In this story

drug diversionnarcotic substancesregulatory gapstech-enabled crimeyouth drug abuseintelligence-led strategy2026-2029 vision document
Get the beta ↗